MoneyWorks4Me

Aarti Pharmalabs - Quaterly Results

05 Aug 2023 Evaluate
Revenue reduced marginally to stand at Rs. 3581.40 millions during the quarter ended June 2023. The figure stood at Rs. 3731.50 millions during the year-ago period.Profit for the quarter ended June 2023 increased merely by0.80% to Rs. 476.30  millions from Rs. 472.50 millions.OP of the company witnessed a marginal growth to 816.00 millions from 787.10 millions in the same quarter last year.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202306 202206 % Var 202306 202206 % Var 202303 202203 % Var
Sales 3581.40 3731.50 -4.02 3581.40 3731.50 -4.02 15112.50 9410.20 60.60
Other Income 48.60 0.00 0.00 48.60 0.00 0.00 12.80 25.10 -49.00
PBIDT 816.00 787.10 3.67 816.00 787.10 3.67 3096.20 1822.90 69.85
Interest 40.30 40.50 -0.49 40.30 40.50 -0.49 204.90 113.40 80.69
PBDT 775.70 746.60 3.90 775.70 746.60 3.90 2891.30 1709.50 69.13
Depreciation 154.40 124.10 24.42 154.40 124.10 24.42 557.70 372.30 49.80
PBT 621.30 622.50 -0.19 621.30 622.50 -0.19 2333.60 1337.20 74.51
TAX 145.00 150.00 -3.33 145.00 150.00 -3.33 616.30 270.00 128.26
Deferred Tax 35.00 22.50 55.56 35.00 22.50 55.56 95.00 45.00 111.11
PAT 476.30 472.50 0.80 476.30 472.50 0.80 1717.30 1067.20 60.92
Equity 453.10 453.10 0.00 453.10 453.10 0.00 453.10 455.60 -0.55
PBIDTM(%) 22.78 21.09 8.02 22.78 21.09 8.02 20.49 19.37 5.76
Peers
Company Name CMP
Sun Pharma. Inds. 1853.00
Dr. Reddys Labs. 1200.40
Cipla 1404.00
Lupin 2098.00
Zydus Lifesciences 1180.00
View more..